[Efficacy and safety of transcatheter arterial chemoembolization followed by hepatic arterial infusion chemotherapy combined with TKI and PD-1 inhibitors as first-line treatment for advanced hepatocellular carcinoma].
The first-line treatment with TACE+HAIC+PD-1+TKI is safe and effective for advanced HCC and can significantly prolong the survival of the patients.
Authors
- Xiaohan Hu (ORCID: https://orcid.org/0000-0002-5608-2864)
- Hongjuan You (ORCID: https://orcid.org/0009-0000-7862-2166)
- Jian Wang (ORCID: https://orcid.org/0000-0003-2291-640X)
- Xiaojun Liu (ORCID: https://orcid.org/0000-0002-6324-5932)
- Haibo Zhang (ORCID: https://orcid.org/0000-0003-1755-1813)
- Gang Li (ORCID: https://orcid.org/0000-0002-3981-2239)
- Xiaohua Yu (ORCID: https://orcid.org/0000-0003-3341-8377)
- Qian Zhang (ORCID: https://orcid.org/0000-0001-5975-9781)
- Lifu Zhang (ORCID: https://orcid.org/0000-0002-3533-9966)
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Integrated Chinese Medicine (China) (HK)
- Guangdong Provincial Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-09-20
- DOI
- https://doi.org/10.12122/j.issn.1673-4254.2024.09.24
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article